Our AgTech portfolio company GreenLight Biosciences, Inc., recently made a very exciting announcement: a $50 million first closing of its latest funding round. This company is impressive in many ways, and we were delighted to participate in this round, along with a forward-thinking investor syndicate. GreenLight provides a unique cell-free bioproduction platform. In a wholly scalable fashion, GreenLight gives cost-effective, high-quality solutions to human, animal, and plant challenges.

Read more, here.